← FDA Drug Approvals (Drugs@FDA)
NATEGLINIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2011-03-30
Drug application
- FDA Application #
ANDA077462- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NATEGLINIDE
- Generic name
- Nateglinide
- Active ingredients
- NATEGLINIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- WATSON LABS
- First approval
- 2011-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown